(0.25%) 5 167.75 points
(0.20%) 38 909 points
(0.23%) 18 043 points
(0.91%) $78.82
(0.05%) $2.14
(0.77%) $2 326.40
(2.58%) $27.38
(1.31%) $977.95
(-0.02%) $0.929
(-0.23%) $10.85
(-0.25%) $0.795
(0.04%) $91.48
4 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 0.00%
-0.49% ¥ 3 064.00
Live Chart Being Loaded With Signals
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams...
Stats | |
---|---|
Dzisiejszy wolumen | 492 500 |
Średni wolumen | 879 975 |
Kapitalizacja rynkowa | 699.02B |
EPS | ¥0 ( 2024-02-09 ) |
Następna data zysków | ( ¥0 ) 2024-05-10 |
Last Dividend | ¥12.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 22.68 |
ATR14 | ¥1.480 (0.05%) |
Wolumen Korelacja
Rohto Pharmaceutical Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Rohto Pharmaceutical Korelacja - Waluta/Towar
Rohto Pharmaceutical Finanse
Annual | 2022 |
Przychody: | ¥238.66B |
Zysk brutto: | ¥137.42B (57.58 %) |
EPS: | ¥115.62 |
FY | 2022 |
Przychody: | ¥238.66B |
Zysk brutto: | ¥137.42B (57.58 %) |
EPS: | ¥115.62 |
FY | 2022 |
Przychody: | ¥199.65B |
Zysk brutto: | ¥116.49B (58.35 %) |
EPS: | ¥92.13 |
FY | 2021 |
Przychody: | ¥181.05B |
Zysk brutto: | ¥106.73B (58.95 %) |
EPS: | ¥292.72 |
Financial Reports:
No articles found.
Rohto Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥10.00 (N/A) |
¥0 (N/A) |
¥12.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥3.75 | 2001-03-27 |
Last Dividend | ¥12.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥208.50 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.98 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.69 | |
Div. Directional Score | 8.40 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8410.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7820.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6966.T | Ex Dividend Knight | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
6323.T | Ex Dividend Knight | 2024-02-28 | Annually | 0 | 0.00% | |
5142.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4272.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3464.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
2651.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
9514.T | Ex Dividend Junior | 2024-06-27 | Annually | 0 | 0.00% | |
8129.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.117 | 1.500 | 7.66 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0903 | 1.200 | 6.99 | 8.39 | [0 - 0.3] |
returnOnEquityTTM | 0.137 | 1.500 | 9.59 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.56 | 0.800 | 2.19 | 1.755 | [1 - 3] |
quickRatioTTM | 1.852 | 0.800 | 3.81 | 3.05 | [0.8 - 2.5] |
cashRatioTTM | 0.979 | 1.500 | 5.67 | 8.51 | [0.2 - 2] |
debtRatioTTM | 0.0282 | -1.500 | 9.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 174.35 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 74.69 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 74.69 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0401 | -1.500 | 9.84 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.582 | 1.000 | 3.64 | 3.64 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.154 | 1.000 | 8.92 | 8.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.769 | 1.000 | 1.283 | 1.283 | [0.2 - 2] |
assetTurnoverTTM | 0.770 | 0.800 | 8.20 | 6.56 | [0.5 - 2] |
Total Score | 11.11 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 22.62 | 1.000 | 7.82 | 0 | [1 - 100] |
returnOnEquityTTM | 0.137 | 2.50 | 9.74 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 74.69 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.881 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 74.69 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.864 | 1.500 | 7.57 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0647 | 1.000 | -0.884 | 0 | [0.1 - 0.5] |
Total Score | 5.69 |
Rohto Pharmaceutical
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej